Janet K. Snell-Bergeon
Anschutz Medical Campus
244 Papers
931 Citations
Janet K. Snell-Bergeon is an academic researcher from Anschutz Medical Campus. The author has contributed to research in topics: Diabetes mellitus & Type 1 diabetes. The author has an hindex of 44, co-authored 185 publications. Previous affiliations of Janet K. Snell-Bergeon include University of Colorado Boulder & Colorado School of Public Health.
Chat about Author
Papers
Acute Hyperinsulinemia Alters Bone Turnover in Women and Men With Type 1 Diabetes.
Vanessa D. Sherk,Tim Vigers,Laura Pyle,Janet K. Snell-Bergeon,Kristen J. Nadeau,Michael R. Rickels,Kellee M. Miller,Carla J. Greenbaum,Viral N. Shah +8 more
- 01 Sep 2020
TL;DR: Exogenous hyperinsulinemia acutely alters bone turnover, suggesting a need to determine whether strategies to promote healthy remodeling may protect bone quality in T1D and why SCL was the only BTM that changed differently in women than men.
5
A randomized controlled trial of transition from insulin pump to multiple daily injections using insulin degludec
TL;DR: In this paper, the authors evaluated two methods of transition from an insulin pump to multiple daily injections (MDI) using long-acting insulin degludec (IDeg), and found that the overlap transition method may result in a significant improvement in time-in-range without increasing hypoglycaemia during the first week.
4
Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes.
TL;DR: A critical gap in knowledge is addressed in an article in this issue of the journal through the development of a questionnaire that allows for a better understanding of the impact of insulin delivery devices on quality of life and diabetes management among both type 1 diabetes and insulin-dependent type 2 diabetes patients.
4
175-OR: Pregnancy Intervention with a Closed-Loop System (PICLS) Study
Elizabeth O. Buschur,Janet K. Snell-Bergeon,Laura Pyle,Rachel Garcetti,Kathleen Dungan,Stephen F. Thung,Anna Bartholomew,Taryn Summerfield,Sarit Polsky +8 more
TL;DR: In this paper , a parallel, two-site, randomized controlled trial of a commercially available hybrid closed-loop (HCL) system compared to sensor augmented pump therapy (SAPT) in pregnant women with type 1 diabetes (T1D) was performed.
4